Endothelial-monocyte activating polypeptide II alters fibronectin based endothelial cell adhesion and matrix assembly via alpha5 beta1 integrin

Experimental Cell Research

Volumn 311, Issue 2, 2005, Pages 229-239

  Schwarz, Margaret A ^a   Zheng, Hiahua ^a   Liu, Jie ^a   Corbett, Siobhan ^a   Schwarz, Roderich E ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Adhesion; alphaV beta3; Anti angiogenesis; EMAP II; Integrin; Microvascular endothelium; P43

Indexed keywords

ACTIN; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II; FIBRONECTIN; VERY LATE ACTIVATION ANTIGEN 5;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL SPREADING; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; FETUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STRESS FIBER;

ANIMALIA;

EID: 27744436481     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.09.008     Document Type: Article

References (41)

1. D.E. Ingber Extracellular matrix as a solid-state regulator in angiogenesis: identification of new targets for anti-cancer therapy Semin. Cancer Biol. 3 1992 57 63
2. Y.D. Jung, S.A. Ahmad, W. Liu, N. Reinmuth, A. Parikh, O. Stoeltzing, F. Fan, and L.M. Ellis The role of the microenvironment and intercellular cross-talk in tumor angiogenesis Semin. Cancer Biol. 12 2002 105 112
3. S.E. Francis, K.L. Goh, K. Hodivala-Dilke, B.L. Bader, M. Stark, D. Davidson, and R.O. Hynes Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies Arterioscler., Thromb., Vasc. Biol. 22 2002 927 933
4. R.O. Hynes A reevaluation of integrins as regulators of angiogenesis Nat. Med. 8 2002 918 921
5. D. Taverna, and R.O. Hynes Reduced blood vessel formation and tumor growth in alpha5-integrin-negative teratocarcinomas and embryoid bodies Cancer Res. 61 2001 5255 5261
6. C. Chang, and Z. Werb The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis Trends Cell Biol. 11 2001 S37 S43
7. Y.A. DeClerck, A.M. Mercurio, M.S. Stack, H.A. Chapman, M.M. Zutter, R.J. Muschel, A. Raz, L.M. Matrisian, B.F. Sloane, A. Noel, M.J. Hendrix, L. Coussens, and M. Padarathsingh Proteases, extracellular matrix, and cancer: a workshop of the path B study section Am. J. Pathol. 164 2004 1131 1139
8. M.M. Handsley, and D.R. Edwards Metalloproteinases and their inhibitors in tumor angiogenesis Int. J. Cancer 23 2005 23
9. N.E. Sounni, and A. Noel Membrane type-matrix metalloproteinases and tumor progression Biochimie 87 2005 329 342
10. Y. Maeshima, P.C. Colorado, and R. Kalluri Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties J. Biol. Chem. 275 2000 23745 23750
11. M. Rehn, T. Veikkola, E. Kukk-Valdre, H. Nakamura, M. Ilmonen, C. Lombardo, T. Pihlajaniemi, K. Alitalo, and K. Vuori Interaction of endostatin with integrins implicated in angiogenesis Proc. Natl. Acad. Sci. U. S. A. 98 2001 1024 1029 (Electronic publication 2001 Jan 23)
12. A. Sudhakar, H. Sugimoto, C. Yang, J. Lively, M. Zeisberg, and R. Kalluri Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins Proc. Natl. Acad. Sci. U. S. A. 100 2003 4766 4771
13. S.A. Wickstrom, T. Veikkola, M. Rehn, T. Pihlajaniemi, K. Alitalo, and J. Keski-Oja Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells Cancer Res. 61 2001 6511 6516
14. J. Kao, Y.G. Fan, I. Haehnel, M. Clauss, and D. Stern Endothelial-monocyte activating polypeptides (EMAPs): tumor derived mediators which activate the host inflammatory response Behring Inst. Mitt. 92 1993 92 106
15. J. Kao, K. Houck, Y. Fan, I. Haehnel, S.K. Libutti, M.L. Kayton, T. Grikscheit, J. Chabot, R. Nowygrod, and S. Greenberg Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II J. Biol. Chem. 269 1994 25106 25119
16. M.A. Schwarz, J. Kandel, G. Brett, J. Li, J. Hayward, R.E. Schwarz, O. Chappey, J. Wautier, J. Chabot, P. Lo Gerfo, and D. Stern Endothelial-monocyte activating II. Polypeptide, a novel antitumor cytokine that suppresses primary and metastatic tumor growth, and induces apoptosis in growing endothelial cells J. Exp. Med. 190 1999 341 353
17. A. Ferrario, K. Tiehl, N. Rucker, M. Schwarz, P. Gill, and C. Gomer Anti-angiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma Cancer Res. 60 2000 4066 4069
18. M.J. Acarregui, K.M. England, J.T. Richman, and J.L. Littig Characterization of CD34+ cells isolated from human fetal lung Am. J. Physiol.: Lung Cell. Mol. Physiol. 284 2003 L395 L401 (Electronic publication 2002 Oct. 11)
19. D.P. Ly, K.M. Zazzali, and S.A. Corbett De novo expression of the integrin alpha5beta1 regulates alphavbeta3-mediated adhesion and migration on fibrinogen J. Biol. Chem. 278 2003 21878 21885
20. M.A. Schwarz, F. Zhang, S. Gebb, V. Starnes, and D. Warburton EMAP II inhibits lung neovascularization and airway epithelial morphogenesis Mech. Dev. 95 2000 123 132
21. A.C. Berger, H.R. Alexander, G. Tang, P.S. Wu, S.M. Hewitt, E. Turner, E. Kruger, W.D. Figg, A. Grove, E. Kohn, D. Stern, and S.K. Libutti Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis Microvasc. Res. 60 2000 70 80
22. A.C. Berger, G. Tang, H.R. Alexander, and S.K. Libutti Endothelial monocyte-activating polypeptide II, a tumor-derived cytokine that plays an important role in inflammation, apoptosis, and angiogenesis J. Immunother. 23 2000 519 527
23. M.A. Schwarz, Z. Wan, J. Liu, and M.K. Lee Epithelial-mesenchymal interactions are linked to neovascularization Am. J. Respir. Cell Mol. Biol. 30 2004 784 792
24. R.E. Schwarz, and M.A. Schwarz In vivo therapy of local tumor progression by targeting vascular endothelium with EMAP-II J. Surg. Res. 120 2004 64 72
25. J.D. Coffin, J. Harrison, S. Schwartz, and R. Heimark Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo Dev. Biol. 148 1991 51 62
26. T.J. Poole, and J.D. Coffin Vasculogenesis and angiogenesis: two distinct morphogenetic mechanisms establish embryonic vascular pattern J. Exp. Zool. 251 1989 224 231
27. M. Ziche, S. Donnini, and L. Morbidelli Development of new drugs in angiogenesis Curr. Drug Targets 5 2004 485 493
28. K. Burridge, K. Fath, T. Kelly, G. Nuckolls, and C. Turner Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton Annu. Rev. Cell Biol. 4 1988 487 525
29. P.C. Colorado, A. Torre, G. Kamphaus, Y. Maeshima, H. Hopfer, K. Takahashi, R. Volk, E.D. Zamborsky, S. Herman, P.K. Sarkar, M.B. Ericksen, M. Dhanabal, M. Simons, M. Post, D.W. Kufe, R.R. Weichselbaum, V.P. Sukhatme, and R. Kalluri Anti-angiogenic cues from vascular basement membrane collagen Cancer Res. 60 2000 2520 2526
30. S.M. Keezer, S.E. Ivie, H.C. Krutzsch, A. Tandle, S.K. Libutti, and D.D. Roberts Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin Cancer Res. 63 2003 6405 6412
31. E.A. Clark, W.G. King, J.S. Brugge, M. Symons, and R.O. Hynes Integrin-mediated signals regulated by members of the rho family of GTPases J. Cell Biol. 142 1998 573 586
32. C.D. Nobes, and A. Hall Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia Cell 81 1995 53 62
33. J.L. Sechler, A.M. Cumiskey, D.M. Gazzola, and J.E. Schwarzbauer A novel RGD-independent fibronectin assembly pathway initiated by alpha4beta1 integrin binding to the alternatively spliced V region J. Cell Sci. 113 2000 1491 1498
34. Z. Cao, K. Huang, and A.F. Horwitz Identification of a domain on the integrin alpha5 subunit implicated in cell spreading and signaling J. Biol. Chem. 273 1998 31670 31679
35. K. Eto, W. Puzon-McLaughlin, D. Sheppard, A. Sehara-Fujisawa, X.P. Zhang, and Y. Takada RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction J. Biol. Chem. 275 2000 34922 34930
36. C. Marcinkiewicz, J.J. Calvete, M.M. Marcinkiewicz, M. Raida, S. Vijay-Kumar, Z. Huang, R.R. Lobb, and S. Niewiarowski EC3, a novel heterodimeric disintegrin from Echis carinatus venom, inhibits alpha4 and alpha5 integrins in an RGD-independent manner J. Biol. Chem. 274 1999 12468 12473
37. S.Y. Chang, H.J. Ko, T.H. Heo, and C.Y. Kang Heparan sulfate regulates the antiangiogenic activity of endothelial monocyte-activating polypeptide-II at acidic pH Mol. Pharmacol. 67 2005 1534 1543
38. S.Y. Chang, S.G. Park, S. Kim, and C.Y. Kang Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation J. Biol. Chem. 277 2002 8388 8394
39. M.L. Wahl, D.J. Kenan, M. Gonzalez-Gronow, and S.V. Pizzo Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated J. Cell. Biochem. 96 2 2005 242 261 (Oct 1)
40. C.H. Damsky, and D. Ilic Integrin signaling: it's where the action is Curr. Opin. Cell Biol. 14 2002 594 602
41. C. Zhong, M. Chrzanowska-Wodnicka, J. Brown, A. Shaub, A.M. Belkin, and K. Burridge Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly J. Cell Biol. 141 1998 539 551